Revolution Medicines · 2 months ago
Senior Director, Cancer Immunology
Redwood City, California, United States
Full-time
Onsite
Director/Executive
$236K/yr - $295K/yrRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. This role represents a unique opportunity to serve as a strategic and scientific leader within Cancer Immunology, overseeing discovery programs and leading a multidisciplinary team to advance novel immuno-oncology targets.
Health CareLife ScienceMedical
Responsibilities
Lead Cancer Immunology discovery programs from project qualification through Development Candidate nomination
Drive the identification and validation of novel immuno-oncology targets, ensuring seamless progression of programs into Translational Cancer Immunology
Oversee the development and optimization of experimental platforms, including in vitro and in vivo models, phenotypic screening, and advanced assay toolkits
Champion the exploration and implementation of new therapeutic modalities, such as TCEs, ADCs, and bispecifics
Provide strategic oversight of scientific integration across Discovery and Translational Cancer Immunology, ensuring operational rigor, platform support, and alignment of resources
Leverage enabling functions and data-driven insights to enhance experimental design, reproducibility, and program execution
Promote the development and deployment of modern data systems and analytics to advance scientific and operational excellence, enabling the establishment of a digitally empowered Cancer Immunology team within the broader organization
Partner with Research Leadership to support advancement of programs from early discovery into the clinical development portfolio
Foster collaboration across multidisciplinary teams to ensure that discovery efforts, platform capabilities including data platforms, and translational priorities are coordinated and integrated
Lead, mentor, and inspire a multidisciplinary team of PhD and non-PhD scientists
Cultivate a culture of scientific excellence, innovation, and collaboration
Spearhead collaborations with academic partners and external organizations
Partner with key stakeholders to define publication strategies and support advancement of the company’s scientific reputation in the field
Qualification
Required
Ph.D. in immunology, cancer biology, or a related discipline, with deep expertise in tumor immunology, immune-evasive oncogenic signaling pathways, and/or immunotherapy
Demonstrated track record of excellence in research, evidenced by high-impact publications
Experience in oncology drug discovery and development, including experience with antibody-directed therapies such as T cell engagers, ADCs, or bispecific antibodies
Proven ability to lead multidisciplinary teams and cross-functional projects, with excellent people management skills
Strong strategic thinker capable of prioritizing initiatives, anticipating challenges, and executing effectively in a dynamic, high-energy environment
Thrives in a collaborative, interdisciplinary team setting
Excellent written and verbal communication skills, with the ability to influence and align diverse stakeholders
Preferred
Experience with chemistry-based therapies, including small molecules or ADC payloads
Familiarity with bioinformatics-driven discovery and integrating computational insights into experimental design
Demonstrated proficiency with modern data platforms, machine learning approaches, and advanced analytics to support Cancer Immunology research and decision-making
Prior experience as a Program Team Leader, with a track record of driving cross-functional strategy and execution across discovery and development stages
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Founded in 2015
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase